PITTSBURGH, Feb. 29, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business has been named the Pharmacy Generic Supplier of the Year by Novation, one of the health care industry’s leading supply contracting companies, serving the members and affiliates of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. The award was granted at Novation’s Annual Supplier Summit on Feb. 22, 2012, and recognizes Mylan Institutional’s commitment to providing high quality, differentiated pharmaceutical products. Mylan Institutional also was a finalist for the NOVAPLUS® Pharmacy Supplier of the Year Award. The Novation awards were given in recognition of the winners’ superior service provided to the health care organization members of VHA Inc. and UHC.
Mylan Institutional President Matt Erick said: “Mylan is committed to making service excellence and reliability a habit while innovating to meet unmet needs. This recognition by Novation demonstrates that we are delivering on this mission. We are honored to partner with Novation and their strong member networks in the U.S., and proud of this award as it further demonstrates Mylan’s ability to differentiate itself in an increasingly competitive business environment.”
Mylan Institutional is a customer-focused business providing a differentiated basket of pharmaceutical products, including a strong injectables portfolio, and services to institutional customers, which include group purchasing organizations, wholesalers, hospitals, surgical and radiology services, home infusion service providers, long-term care facilities, correctional facilities, specialty pharmacies, veterinary clinics and retail outlets.
Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.
SOURCE Mylan Inc.
